Literature DB >> 8605976

The presence of a glucose-derived Maillard reaction product in the human lens.

R H Nagaraj1, C Sady.   

Abstract

Pyrraline is an advanced Maillard reaction product formed by the non-enzymatic reaction initiated by glucose with lysine residues on proteins. This reaction involves an intermediate, 3-deoxyglucosone, concentration of which is shown to be elevated in plasma and lenses during diabetes. Bovine lens alpha crystallins incubated with 3-deoxyglucosone showed that pyrraline formation was a major modification and its quantification by two different methods revealed time-dependent accumulation. Pyrraline was quantified in normal, senile cataractous and diabetic lenses. Although a wide variation was observed, the mean value in cataractous lenses (mean +/- S.E.: 48.4 +/- 12.67 pmol/mg protein) was higher than in age-matched normal lenses (30.9 +/- 10.26 pmol). Surprisingly, in diabetic lenses, the mean value was lower than normal lenses (28.4 +/- 15.3 pmol). These results suggest that glucose-specific advanced Maillard products occur in the human lens and such modifications may play a role in lens aging and cataract formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605976     DOI: 10.1016/0014-5793(96)00142-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  Pathways of the Maillard reaction under physiological conditions.

Authors:  Christian Henning; Marcus A Glomb
Journal:  Glycoconj J       Date:  2016-06-13       Impact factor: 2.916

2.  Glutathionylation of lens proteins through the formation of thioether bond.

Authors:  Mikhail Linetsky; Roy D LeGrand
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Advanced glycation end products in human optic nerve head.

Authors:  S Amano; Y Kaji; T Oshika; T Oka; R Machinami; R Nagai; S Horiuchi
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

4.  Advanced glycation end products in human senile and diabetic cataractous lenses.

Authors:  S Zarina; H R Zhao; E C Abraham
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

5.  Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract.

Authors:  Zehra Hashim; Shamshad Zarina
Journal:  Age (Dordr)       Date:  2010-09-15

6.  Effect of site-directed mutagenesis of methylglyoxal-modifiable arginine residues on the structure and chaperone function of human alphaA-crystallin.

Authors:  Ashis Biswas; Antonia Miller; Tomoko Oya-Ito; Puttur Santhoshkumar; Manjunatha Bhat; Ram H Nagaraj
Journal:  Biochemistry       Date:  2006-04-11       Impact factor: 3.162

7.  Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats.

Authors:  Megha Saraswat; Palla Suryanarayana; Paduru Yadagiri Reddy; Madhoosudan A Patil; Nagalla Balakrishna; Geereddy Bhanuprakash Reddy
Journal:  Mol Vis       Date:  2010-08-10       Impact factor: 2.367

8.  Glycation by ascorbic acid oxidation products leads to the aggregation of lens proteins.

Authors:  Mikhail Linetsky; Ekaterina Shipova; Rongzhu Cheng; Beryl J Ortwerth
Journal:  Biochim Biophys Acta       Date:  2007-10-16

9.  Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses.

Authors:  Rajko Pokupec; Miro Kalauz; Niksa Turk; Zdenka Turk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

10.  Isolation, purification and characterization of histidino-threosidine, a novel Maillard reaction protein crosslink from threose, lysine and histidine.

Authors:  Zhenyu Dai; Ina Nemet; Wei Shen; Vincent M Monnier
Journal:  Arch Biochem Biophys       Date:  2007-04-02       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.